BLACAT1 and gastric cancer: Wu., et al. [77] has verified that bladder cancer associated transcript-1 (BLACAT1), a novel gene regulator lncRNA, could provoke the oxaliplatin(OXA)-resistance in gastric cancer through combining with miR-361, providing a novel insight and a potential therapeutic mechanism towards cancer chemoresistance.